Gerresheimer
Gerresheimer: Partner for the pharma and healthcare industry.
Launch date
Employees
Market cap
€3.6b
Enterprise valuation
€4.6b (Public information from Sep 2024)
Share price
€101.8 GXI.DE
Düsseldorf Nordrhein-Westfalen (HQ)
Financials
Estimates*
EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.4b | 1.5b | 1.8b | 2.0b | 2.1b | 2.4b | 2.7b |
% growth | - | 6 % | 21 % | 10 % | 6 % | 16 % | 10 % |
EBITDA | 324m | 325m | 390m | 418m | 438m | 551m | 620m |
% EBITDA margin | 23 % | 22 % | 21 % | 21 % | 21 % | 23 % | 23 % |
Profit | 88.6m | 83.8m | 96.1m | 116m | 141m | 195m | 241m |
% profit margin | 6 % | 6 % | 5 % | 6 % | 7 % | 8 % | 9 % |
EV / revenue | 2.8x | 1.9x | 1.8x | 2.0x | 2.2x | 1.9x | 1.7x |
EV / EBITDA | 12.4x | 8.8x | 8.5x | 9.4x | 10.4x | 8.2x | 7.2x |
R&D budget | 7.7m | 10.0m | 21.6m | 16.1m | - | - | - |
R&D % of revenue | 1 % | 1 % | 1 % | 1 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Acquisition | ||
N/A | N/A | IPO | |
* | N/A | €272m | Private Placement non VC |
Total Funding | - |
Related Content
Recent News about Gerresheimer
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Gerresheimer
EditACQUISITION by Gerresheimer Jul 2018
ACQUISITION by Gerresheimer May 2024